At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.

CRL's reputation for quality and reliability ... Since then, we have evolved into a global financial technology leader providing market data and services to the global financial, media, and ...

Czech National Bank boosted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.4% in the fourth quarter, according to the company in its most recent Form 13F ...